Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Danielle Maria Camelo Cid

Showing results (1-10 of 3) with videos related to

Pageof 1
Sort By:
Revista Do Colegio Brasileiro De Cirurgioes|January 23, 2020
Low-cost synthetic tourniquet training modelDaniel Souza Lima, Yuri Augusto da Silva Almeida, Danielle Maria Camelo Cid, et al.
Revista Brasileira De Hematologia E Hemoterapia|August 2, 2013
Adherence to treatment with imatinib in chronic myeloid leukemia: a study of the first decade of responses obtained at a Brazilian hospitalSamuel Roosevelt Campos Dos Reis, Acy Telles de Souza Quixadá, Sammara Tavares Nunes, et al.
Revista Brasileira De Hematologia E Hemoterapia|January 31, 2014
Chronic myeloid leukemia: an overview of the determinants of effectiveness and therapeutic response in the first decade of treatment with imatinib mesylate in a Brazilian hospitalDanielle Maria Camelo Cid, Silvia Maria Meira Magalhães, Acy Telles de Souza Quixadá, et al.
Pageof 1

Showing results (1-10 of 3) with videos related to

Sort By:
Pageof 1
Revista Do Colegio Brasileiro De Cirurgioes|January 23, 2020
Low-cost synthetic tourniquet training modelDaniel Souza Lima, Yuri Augusto da Silva Almeida, Danielle Maria Camelo Cid, et al.
Revista Brasileira De Hematologia E Hemoterapia|August 2, 2013
Adherence to treatment with imatinib in chronic myeloid leukemia: a study of the first decade of responses obtained at a Brazilian hospitalSamuel Roosevelt Campos Dos Reis, Acy Telles de Souza Quixadá, Sammara Tavares Nunes, et al.
Revista Brasileira De Hematologia E Hemoterapia|January 31, 2014
Chronic myeloid leukemia: an overview of the determinants of effectiveness and therapeutic response in the first decade of treatment with imatinib mesylate in a Brazilian hospitalDanielle Maria Camelo Cid, Silvia Maria Meira Magalhães, Acy Telles de Souza Quixadá, et al.
Pageof 1